What to watch with FADS1 and weight loss?

FADS1 encodes a delta-5 desaturase that converts linoleic acid to arachidonic acid and alpha-linolenic acid to EPA/DHA. Variants like rs174537 alter enzyme activity. During weight loss, this matters because dietary fat composition influences inflammation, insulin sensitivity, and lipid metabolism. Carriers of risk variants often have lower arachidonic acid and higher linoleic acid levels, which may affect metabolic responses. Some studies suggest that individuals with certain FADS1 genotypes respond differently to omega-3 supplementation or low-fat vs. low-carb diets. For weight loss, watch your omega-6/omega-3 ratio, limit excessive linoleic acid from processed vegetable oils, and consider personalized fat intake. Evidence is based on GWAS and human observational studies, not on large RCTs with weight loss as primary outcome. Thus, the clinical utility for weight management is moderate. A MyBody-X test can provide insight but should be interpreted with a professional. Safety note: avoid extreme dietary fat changes without medical supervision.